Hecht Patrick M, Will Matthew J, Schachtman Todd R, Welby Lauren M, Beversdorf David Q
Interdisciplinary Neuroscience Program, University of Missouri, Columbia, MO 65211, USA; Thompson Center for Autism and Neurodevelopmental Disorders, University of Missouri, Columbia, MO 65211, USA; Center for Translational Neuroscience, University of Missouri, Columbia, MO 65211, USA.
Interdisciplinary Neuroscience Program, University of Missouri, Columbia, MO 65211, USA; Thompson Center for Autism and Neurodevelopmental Disorders, University of Missouri, Columbia, MO 65211, USA; Christopher Bond Life Sciences Center, University of Missouri, Columbia, MO 65211, USA; Department of Psychological Sciences, University of Missouri, Columbia, MO 65211, USA.
Behav Brain Res. 2014 Mar 1;260:148-54. doi: 10.1016/j.bbr.2013.11.041. Epub 2013 Dec 1.
Previous work examining animal models of cognitive flexibility have focused on tasks where animals are required to shift between cues in order to reach a food reward from among a limited set of choices. Performance by nonhuman animals on these tasks, including reversal learning, intradimensional set-shifting, and extradimensional set-shifting, are affected by pharmacological action on serotonergic, dopaminergic, and alpha-adrenergic, but not beta-adrenergic receptors. However, beta-adrenergic antagonists, such as propranolol, are widely utilized for conditions such as test anxiety. Propranolol improves performance in humans during cognitive flexibility tasks where there is a broad set of potential solutions. The current investigation utilized a digging task where the rodent must develop a novel solution in order to obtain a reward. Similar to the effects observed in humans, propranolol improved performance on this task, while not affecting performance on set-shifting tasks, as with previous animal studies. This may allow future investigation of the neurobiological mechanism by which propranolol affects context-specific anxiety, and could provide insight into the neurobiology of creativity.
以往对认知灵活性动物模型的研究主要集中在一些任务上,即要求动物在有限的一组选择中切换线索以获取食物奖励。非人类动物在这些任务中的表现,包括反转学习、维度内集合转换和维度间集合转换,会受到对5-羟色胺能、多巴胺能和α-肾上腺素能受体而非β-肾上腺素能受体的药理作用的影响。然而,β-肾上腺素能拮抗剂,如普萘洛尔,被广泛用于治疗考试焦虑等病症。在存在广泛潜在解决方案的认知灵活性任务中,普萘洛尔可提高人类的表现。当前的研究采用了一种挖掘任务,啮齿动物必须想出一种新的解决方案才能获得奖励。与在人类中观察到的效果类似,普萘洛尔改善了该任务的表现,同时与之前的动物研究一样,不影响集合转换任务的表现。这可能有助于未来对普萘洛尔影响情境特异性焦虑的神经生物学机制进行研究,并可能为创造力的神经生物学提供见解。